RAISING $100 MILLION FOR A STEM CELL DIABETES TREATMENT
An American startup that wants to develop a permanent treatment for type 1 diabetes just raised $114 million to fund their stem cell-driven cure. By utilizing the immense potential of stem cells, Semma Therapeutics' research revolves around having them perform like key cells that manage blood sugar levels in our bodies. The endgame is to treat - and permanently cure - type 1 diabetes. The $114 million, combined with the $49 million they previously raised, will be put towards getting Semma's treatment, which have been tested on animals, to human trials. $163 MILLION FOR 30 MILLION PEOPLE Diabetes is an autoimmune disease in which the body doesn't breakdown sugar in the blood correctly. The body confuses beta cells found in the pancreas, which are supposed to produce insulin, and attacks them, affecting how the [...]



